Best Biotech Stocks to Buy Now (2022)Top biotech stocks in 2022 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Consensus | Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CPRX | CATALYST PHARMACEUTICALS INC | $682.46M | $6.64 | $11.60 | 74.70% | Strong Buy | 5 | 17.24% | 26.47% | 42.94% | 38.29% | |
| HALO | HALOZYME THERAPEUTICS INC | $6.47B | $46.90 | $53.00 | 13.01% | Buy | 2 | 26.73% | 9.13% | 276.16% | 61.84% | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $3.05B | $51.67 | $58.25 | 12.73% | Strong Buy | 4 | 31.43% | 66.12% | 136.26% | 62.99% | |
| SESN | SESEN BIO INC | $163.16M | $0.82 | N/A | N/A | Hold | 1 | 24.42% | N/A | -25.40% | -19.43% | |
| EXEL | EXELIXIS INC | $7.13B | $22.22 | $32.00 | 44.01% | Strong Buy | 7 | 12.36% | 18.31% | 28.11% | 24.29% | |
| INCY | INCYTE CORP | $17.32B | $78.19 | $86.14 | 10.17% | Buy | 7 | 14.21% | 11.29% | 47.88% | 36.59% | |
| MRNA | MODERNA INC | $57.38B | $144.27 | $241.30 | 67.26% | Buy | 11 | -38.81% | N/A | 24.20% | 14.97% | |
| UTHR | UNITED THERAPEUTICS CORP | $10.82B | $238.95 | $236.57 | -1.00% | Strong Buy | 8 | 8.78% | 10.16% | 24.97% | 19.46% | |
| CLNN | CLENE INC | $183.44M | $2.90 | $10.00 | 244.83% | Strong Buy | 1 | 593.79% | 37.51% | 29,824.97% | 1,127.36% | |
| REGN | REGENERON PHARMACEUTICALS INC | $67.28B | $612.49 | $717.00 | 17.06% | Buy | 15 | -7.95% | -16.34% | 24.64% | 18.63% | |
| CRSP | CRISPR THERAPEUTICS AG | $5.19B | $66.96 | $103.92 | 55.20% | Buy | 14 | -10.77% | N/A | 11.21% | 9.66% | |
| CDMO | AVID BIOSERVICES INC | $963.83M | $15.61 | $31.67 | 102.86% | Buy | 4 | 34.56% | 101.56% | 70.94% | 12.78% | |
| GMAB | GENMAB A | $21.24B | $32.31 | $37.35 | 15.59% | Hold | 8 | 29.45% | 45.00% | 4.79% | 4.36% | |
| VRTX | VERTEX PHARMACEUTICALS INC | $74.82B | $292.55 | $268.83 | -8.11% | Buy | 13 | 7.31% | 14.07% | 34.47% | 26.37% | |
| XOMA | XOMA CORP | $237.56M | $20.80 | $49.00 | 135.58% | Buy | 3 | 8.62% | 0.38% | 25.47% | 22.39% | |
| AVIR | ATEA PHARMACEUTICALS INC | $593.63M | $7.13 | $8.00 | 12.20% | Sell | 3 | 10.62% | 3.76% | 2.45% | 2.32% | |
| CORT | CORCEPT THERAPEUTICS INC | $2.53B | $23.80 | $30.00 | 26.05% | Strong Buy | 2 | 9.29% | 6.62% | 39.08% | 34.05% | |
| LJPC | LA JOLLA PHARMACEUTICAL CO | $88.42M | $3.46 | $4.00 | 15.61% | Hold | 1 | 13.43% | 32.16% | -25.01% | 18.30% | |
| TECH | BIO-TECHNE CORP | $13.84B | $352.76 | $481.67 | 36.54% | Hold | 3 | 8.78% | 20.57% | 22.11% | 16.48% | |
| UPC | UNIVERSE PHARMACEUTICALS INC | $14.33M | $0.66 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| QURE | UNIQURE NV | $891.44M | $19.11 | $51.25 | 168.18% | Strong Buy | 4 | -27.54% | N/A | -14.87% | -10.72% | |
| XNCR | XENCOR INC | $1.61B | $27.12 | $50.00 | 84.37% | Strong Buy | 4 | -36.58% | N/A | -18.03% | -16.03% | |
| PRTA | PROTHENA CORP PUBLIC LTD CO | $1.30B | $27.77 | $68.67 | 147.27% | Strong Buy | 9 | -6.36% | N/A | -5.87% | -4.43% | |
| GNFT | GENFIT SA | $168.38M | $3.38 | $9.00 | 166.27% | Buy | 2 | 11.14% | -9.30% | 9.62% | 4.07% | |
| CLSD | CLEARSIDE BIOMEDICAL INC | $99.25M | $1.65 | $10.00 | 506.06% | Buy | 2 | -26.32% | N/A | -130.91% | -115.10% | |
| BNTX | BIONTECH SE | $32.57B | $134.04 | $291.71 | 117.63% | Buy | 8 | -49.75% | -67.73% | -9.63% | -7.55% | |
| SELB | SELECTA BIOSCIENCES INC | $201.91M | $1.33 | $5.33 | 300.98% | Buy | 3 | -34.92% | N/A | -62.61% | -23.97% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $9.39B | $98.24 | $113.77 | 15.81% | Buy | 13 | 16.77% | 87.56% | 49.61% | 32.18% | |
| IMTX | IMMATICS NV | $539.29M | $8.57 | $26.00 | 203.38% | Buy | 1 | -50.82% | N/A | -23.97% | -9.85% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $1.59B | $11.20 | $26.00 | 132.14% | Buy | 5 | 83.38% | N/A | 50.61% | 44.74% | |
| VNDA | VANDA PHARMACEUTICALS INC | $604.44M | $10.70 | $12.00 | 12.15% | Hold | 1 | 0.72% | 22.28% | 7.09% | 5.90% | |
| CARA | CARA THERAPEUTICS INC | $503.22M | $9.39 | $26.33 | 180.44% | Strong Buy | 3 | 119.31% | N/A | 37.81% | 34.47% | |
| OPNT | OPIANT PHARMACEUTICALS INC | $64.30M | $12.64 | $42.00 | 232.28% | Buy | 1 | 41.70% | N/A | 122.95% | 80.03% | |
| ATNM | ACTINIUM PHARMACEUTICALS INC | $121.54M | $5.11 | $31.67 | 519.69% | Strong Buy | 4 | 317.97% | N/A | 140.63% | 129.83% | |
| LOGC | LOGICBIO THERAPEUTICS INC | $14.17M | $0.43 | $5.00 | 1,062.79% | Strong Buy | 4 | 57.30% | N/A | 41.02% | 19.69% | |
| RGNX | REGENXBIO INC | $1.14B | $26.50 | $56.67 | 113.84% | Strong Buy | 9 | -20.88% | N/A | -34.34% | -23.09% | |
| SNDX | SYNDAX PHARMACEUTICALS INC | $1.08B | $19.13 | $29.67 | 55.08% | Buy | 3 | -0.50% | N/A | -24.32% | -21.58% | |
| VIR | VIR BIOTECHNOLOGY INC | $3.29B | $24.84 | $59.67 | 140.21% | Buy | 6 | -40.63% | N/A | -2.71% | -1.88% | |
| HCM | HUTCHMED (CHINA) LTD | $2.25B | $13.01 | $49.00 | 276.63% | Buy | 2 | 31.94% | N/A | 64.82% | 46.61% | |
| LUMO | LUMOS PHARMA INC | $61.35M | $7.33 | $28.00 | 281.99% | Buy | 1 | 552.51% | N/A | -26.90% | -23.62% | |
| LPTX | LEAP THERAPEUTICS INC | $106.87M | $1.21 | $5.00 | 313.22% | Strong Buy | 2 | 182.64% | N/A | -41.22% | -38.36% | |
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $93.02M | $8.39 | $21.50 | 156.26% | Strong Buy | 1 | 344.63% | N/A | 108.05% | 95.79% | |
| ABCM | ABCAM PLC | $3.41B | $14.88 | $21.00 | 41.13% | Buy | 6 | 15.50% | 188.20% | 16.65% | 11.08% | |
| ZLAB | ZAI LAB LTD | $3.35B | $34.22 | $133.33 | 289.63% | Strong Buy | 3 | 72.41% | N/A | N/A | N/A | |
| GANX | GAIN THERAPEUTICS INC | $46.58M | $3.92 | $14.00 | 257.14% | Strong Buy | 2 | 49.31% | N/A | -52.64% | -44.56% | |
| RPTX | REPARE THERAPEUTICS INC | $621.71M | $14.84 | $34.40 | 131.81% | Strong Buy | 5 | 48.29% | N/A | -65.76% | -50.45% | |
| ADAG | ADAGENE INC | $87.35M | $2.00 | $15.00 | 650.00% | Strong Buy | 1 | 72.66% | N/A | -163.20% | -134.82% | |
| FBIO | FORTRESS BIOTECH INC | $94.85M | $0.88 | $9.42 | 966.36% | Strong Buy | 6 | 53.08% | N/A | 304.04% | 72.94% | |
| NVO | NOVO NORDISK A S | $259.00B | $112.12 | N/A | N/A | Buy | 4 | 14.81% | 17.23% | 134.81% | 45.51% | |
| SEER | SEER INC | $595.70M | $9.54 | $21.00 | 120.13% | Hold | 1 | 85.12% | N/A | -16.30% | -15.05% | |
| STTK | SHATTUCK LABS INC | $186.89M | $4.41 | $24.00 | 444.22% | Strong Buy | 3 | 190.12% | N/A | -46.99% | -43.24% | |
| SLRX | SALARIUS PHARMACEUTICALS INC | $10.94M | $0.20 | $4.00 | 1,951.28% | Buy | 1 | 292.05% | N/A | -25.19% | -23.71% | |
| ITCI | INTRA-CELLULAR THERAPIES INC | $5.25B | $55.62 | $66.50 | 19.56% | Strong Buy | 6 | 81.83% | N/A | 22.49% | 20.52% | |
| NBRV | NABRIVA THERAPEUTICS PLC | $126.41M | $0.20 | $2.00 | 900.00% | Buy | 1 | 46.33% | N/A | 35.41% | 24.02% | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $269.67M | $6.24 | $27.00 | 332.69% | Strong Buy | 1 | 79.42% | N/A | -32.43% | -20.58% | |
| IMMP | IMMUTEP LTD | $181.93M | $2.13 | $8.15 | 282.63% | Strong Buy | 3 | 33.40% | N/A | -595.40% | -539.30% | |
| INMB | INMUNE BIO INC | $146.62M | $8.17 | $10.50 | 28.52% | Buy | 2 | 498.11% | N/A | N/A | N/A | |
| BYSI | BEYONDSPRING INC | $54.11M | $1.39 | $20.00 | 1,338.85% | Hold | 4 | 268.08% | N/A | 160.47% | 52.45% | |
| EYEN | EYENOVIA INC | $61.09M | $1.82 | $14.00 | 669.23% | Strong Buy | 2 | 51.52% | N/A | 15.77% | 11.69% | |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC | $6.20M | $0.65 | $10.00 | 1,433.74% | Strong Buy | 1 | 320.42% | N/A | -64.02% | -61.53% | |
| ALBO | ALBIREO PHARMA INC | $381.15M | $19.47 | $76.67 | 293.77% | Buy | 3 | 59.89% | N/A | 77.02% | 43.68% | |
| IMGN | IMMUNOGEN INC | $950.51M | $4.31 | $7.33 | 70.14% | Buy | 4 | 44.39% | N/A | 20.87% | 13.28% | |
| LMNL | LIMINAL BIOSCIENCES INC | $14.06M | $0.45 | $2.00 | 341.50% | Hold | 3 | 216.04% | N/A | -34.06% | -14.42% | |
| LEXX | LEXARIA BIOSCIENCE CORP | $19.58M | $3.29 | N/A | N/A | N/A | N/A | 94.40% | N/A | -45.20% | -45.36% | |
| VTGN | VISTAGEN THERAPEUTICS INC | $203.33M | $0.98 | $8.00 | 713.01% | Strong Buy | 2 | 128.24% | N/A | -76.63% | -66.44% | |
| VCYT | VERACYTE INC | $1.62B | $22.74 | $29.80 | 31.05% | Buy | 5 | 13.84% | N/A | -1.98% | -1.83% | |
| VRNA | VERONA PHARMA PLC | $270.45M | $4.48 | $22.00 | 391.07% | Strong Buy | 3 | 56.87% | N/A | 160.59% | 119.80% | |
| SIGA | SIGA TECHNOLOGIES INC | $944.18M | $13.04 | N/A | N/A | N/A | N/A | -6.09% | -14.49% | 31.08% | 28.25% | |
| EDIT | EDITAS MEDICINE INC | $924.60M | $13.47 | $52.00 | 286.04% | Buy | 7 | 39.11% | N/A | -38.55% | -31.73% | |
| FNCH | FINCH THERAPEUTICS GROUP INC | $130.31M | $2.74 | $17.00 | 520.44% | Strong Buy | 1 | 35.25% | N/A | -56.87% | -49.97% | |
| SYBX | SYNLOGIC INC | $79.38M | $1.13 | $7.50 | 563.72% | Strong Buy | 4 | 149.79% | N/A | -38.23% | -31.75% | |
| ORGS | ORGENESIS INC | $62.55M | $2.52 | $9.00 | 257.14% | Strong Buy | 1 | N/A | N/A | N/A | N/A | |
| IVA | INVENTIVA SA | $264.04M | $6.46 | $42.00 | 550.15% | Buy | 1 | -48.93% | N/A | 155.23% | 113.09% | |
| BLI | BERKELEY LIGHTS INC | $391.36M | $5.77 | $11.00 | 90.64% | Hold | 4 | 25.40% | N/A | 11.23% | 8.16% | |
| HSTO | HISTOGEN INC | $5.79M | $2.32 | $1.50 | -35.34% | Buy | 1 | 72.46% | N/A | -55.57% | -36.48% | |
| XENE | XENON PHARMACEUTICALS INC | $1.65B | $31.00 | $43.00 | 38.71% | Buy | 3 | 52.75% | N/A | 1.67% | 1.62% | |
| VCNX | VACCINEX INC | $48.64M | $1.14 | N/A | N/A | Hold | 1 | 1,164.25% | N/A | 324.17% | 289.59% | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $1.56B | $12.33 | $23.50 | 90.59% | Strong Buy | 2 | -36.79% | N/A | -14.50% | -4.13% | |
| RPRX | ROYALTY PHARMA PLC | $26.23B | $43.20 | $49.57 | 14.75% | Strong Buy | 7 | 5.99% | 39.11% | 26.28% | 15.34% | |
| CDXS | CODEXIS INC | $747.08M | $11.44 | $30.00 | 162.24% | Strong Buy | 2 | 20.29% | N/A | 10.70% | 7.22% | |
| ITOS | ITEOS THERAPEUTICS INC | $730.72M | $20.56 | $56.50 | 174.81% | Buy | 2 | -51.24% | N/A | -39.72% | -29.26% | |
| BGNE | BEIGENE LTD | $18.38B | $177.99 | $257.50 | 44.67% | Buy | 2 | 55.28% | N/A | -92.76% | -68.06% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $16.07B | $86.85 | $101.86 | 17.28% | Buy | 8 | 19.54% | 156.86% | 18.58% | 13.46% | |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | $7.26B | $28.45 | $50.67 | 78.09% | Strong Buy | 3 | -8.03% | -17.02% | 114.74% | 21.48% | |
| NVAX | NOVAVAX INC | $4.04B | $51.67 | $187.40 | 262.69% | Buy | 6 | 20.65% | N/A | 1,277.44% | 29.44% | |
| OCUL | OCULAR THERAPEUTIX INC | $306.27M | $3.99 | $18.75 | 369.92% | Strong Buy | 4 | 40.10% | N/A | 0.96% | 0.41% | |
| BLCM | BELLICUM PHARMACEUTICALS INC | $10.42M | $1.21 | $5.00 | 313.22% | Strong Buy | 1 | 55.44% | N/A | N/A | N/A | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $219.21M | $4.35 | $21.71 | 399.17% | Buy | 7 | 153.80% | N/A | -65.19% | -53.96% | |
| SGEN | SEAGEN INC | $33.01B | $179.33 | $165.67 | -7.62% | Buy | 9 | 26.24% | N/A | 35.05% | 29.06% | |
| JANX | JANUX THERAPEUTICS INC | $541.60M | $13.01 | $35.00 | 169.02% | Strong Buy | 3 | 201.68% | N/A | -38.23% | -36.93% | |
| NTRB | NUTRIBAND INC | $30.75M | $3.92 | $14.00 | 257.14% | Strong Buy | 1 | 48.86% | N/A | -17.70% | -16.36% | |
| MREO | MEREO BIOPHARMA GROUP PLC | $223.73M | $1.53 | $5.00 | 226.80% | Buy | 1 | -0.55% | N/A | -197.00% | -137.14% | |
| SYRS | SYROS PHARMACEUTICALS INC | $55.97M | $0.89 | $14.33 | 1,508.64% | Strong Buy | 3 | 28.41% | N/A | 51.06% | 21.07% | |
| JNCE | JOUNCE THERAPEUTICS INC | $144.69M | $2.80 | $13.25 | 373.21% | Buy | 5 | 85.44% | N/A | -22.70% | -19.98% | |
| MESO | MESOBLAST LTD | $330.16M | $2.54 | $2.50 | -1.57% | Strong Sell | 1 | 211.32% | N/A | 221.19% | 167.80% | |
| AVEO | AVEO PHARMACEUTICALS INC | $226.86M | $6.58 | $19.00 | 188.75% | Buy | 1 | 58.27% | N/A | 233.32% | 87.76% | |
| VALN | VALNEVA SE | $1.43B | $27.27 | $56.00 | 105.35% | Strong Buy | 2 | 30.97% | N/A | 369.24% | 77.06% | |
| LQDA | LIQUIDIA CORP | $279.26M | $4.34 | $13.33 | 207.21% | Strong Buy | 3 | 88.59% | N/A | 48.79% | 28.90% | |
| FSTX | F-STAR THERAPEUTICS INC | $137.34M | $6.39 | $21.00 | 228.64% | Buy | 2 | -19.30% | N/A | -63.87% | -49.09% | |
| TYME | TYME TECHNOLOGIES INC | $41.67M | $0.24 | $9.50 | 3,825.62% | Strong Buy | 1 | N/A | N/A | 163.43% | 148.70% |
Biotech Stocks FAQ
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.